Read the endMS Impact Report - Multiple Sclerosis Society of Canada

e n d M S C a M p a i g n i M p a C t R e p o R t

Vancouver
Calgary
Edmonton
Red Deer
Lethbridge
Saskatoon
Regina
endMS Regional Research and Training Centres: Five major hubs across Canada
endMS Network academic and health institutions: 65 institutions across Canada
MS Society funded research: Major MS Society funded research hubs
endMS Summer Schools: Five occurring across Canada since endMS campaign began
Winnipeg
endMS Transitional Career Development Award recipients: Three working in Canada, two in the United States
Thunder Bay Quebec
St. John
Thank you for accelerating MS research in Canada.
London
Ottawa
Toronto
Guelph
Laval
Montreal
Kingston
Sherbrooke
Halifax
St. John’s

M i s s i o n s t a t e M e n t
To be a leader in finding a cure for multiple sclerosis and enabling people
affected by MS to enhance their quality of life.
t a b l e o f c o n t e n t s
Leadership message. ...........................................2
endMS campaign: How and why ..................................3
endMS Regional Research and Training Centres ......................4
endMS Summer School .........................................6
endMS Transitional Career Development Award .......................8
endMS Scholar Program for Researchers in Training ..................10
endMS Conference ............................................11
MS Society research program. ...................................12
endMS campaign donors .......................................15
endMS national campaign cabinet ................................17

Yves Savoie
President & chief executive
officer, MS Society of Canada
With your help, we raised $60 million to secure the next generation of MS researchers. Thank you.
Message from the honorary national campaign chair,
national campaign chair, president & CEO
On behalf of the Multiple Sclerosis Society
of Canada, the Multiple Sclerosis Scientific
Research Foundation and the endMS national
campaign cabinet, we would like to express our
deepest gratitude to all of the generous donors
and committed volunteers who have helped make
the endMS campaign a tremendous success.
Your support has enabled us to raise more
than $60 million for the endMS Research and
Training Network and the ongoing research,
training and collaboration activities of researchers
and trainees focused on ending MS.
Thanks to your investment, the endMS Network
has brought together more than 1,000 experienced
researchers and trainees from more than 65
Canadian academic and health institutions to
collaborate through five endMS Regional Research
and Training Centres. The endMS Network has
attracted, trained and retained talented medical
Sandy Aird
National
campaign chair
Rick Waugh
Honorary national
campaign chair
and research professionals at varying stages of
their careers, in order to secure the future of MS
research in Canada.
Because of the endMS campaign, more
researchers are involved in MS research in
Canada than ever before.
The endMS campaign has achieved its
fundraising goal, but our work must continue.
While great progress has been made to help
people with relapsing-remitting MS, there are
still no effective treatments for those living
with primary-progressive MS. More research
is urgently needed to understand progressive
forms of MS, and people living with this disease
deserve answers about their future quality of life.
We remain committed to raising funds beyond
the endMS campaign so that MS researchers
will have the resources they need to identify
the cause of the disease, improve symptom
management and ultimately find a cure for all
forms of MS.
On behalf of those living with MS and
MS Society volunteers and staff across the
country, please accept our sincere appreciation
for your generous support in helping to make
our endMS campaign a success. Thank you for
helping us in our fight against MS.

endMS campaign and endMS Research and Training
Network: How and why
I’m Dr. Jack Antel, and I want to
congratulate you for making the endMS
campaign a success. I became involved
with the endMS Research and Training
Network because I wanted to secure a
brighter future for MS research – and this
meant attracting, training and retaining
new researchers to the field of MS in
Canada. Thanks to you, our valued
donors and volunteers, our network of
researchers is stronger than ever.
Over the last several decades,
Canadian clinicians and scientists have
contributed to the significant progress
that has been made in understanding
MS, and in the development of
treatments for the disease. This is
thanks in part to the MS Society’s long
history of fostering exceptional MS
researchers and research.
e n d M S C a M p a i g n i M p a C t R e p o R t
You helped ensure that people living with MS will get answers about their disease.
Despite this investment in people and
research, important questions remain
with respect to the cause, prevention
and cure for MS. In this context, the
endMS Research and Training Network
was created with the aim to further
increase Canada’s contribution to
the global effort to end MS in the
shortest possible timeframe.
While there remain many questions
to answer, the endMS campaign
has contributed to accelerating
progress in the field of MS research
in Canada in an unprecedented way.
I believe in a future free of MS, and
through the endMS campaign we are
closer than ever before.
Dr. Jack Antel, scientific director, endMS Research
and Training Network, professor and neurologist,
Montreal Neurological Institute, McGill University
The endMS Research and Training Network complemented and
strengthened the MS Society’s research program. To read more
about how your donations helped fund research through the
MS Society and the MS Scientific Research Foundation, turn to page 12.
e n d M S . c a 2 | 3

Attract
You helped attract researchers to the field of MS.
endMS Regional Research and Training Centres
Dr. Dessa Sadovnick on the impact of the endMS Regional Research and
Training Centres (RRTC)
My connection to MS began before
I was born. I grew up with Evelyn
Opal, MS Society founder, and
her family in Montreal. Back then,
there were little to no resources
and knowledge about MS, so my
community worked together to
care for Evelyn and her family. After
graduating from McGill University
with a master’s degree in genetics,
Evelyn encouraged me to study
MS. I’m not sure I would have
chosen the field without my early
exposure to the disease.
Students need mentors to guide
them early in their careers. When I
was a young researcher, genetics
were thought to be a futile avenue
for MS research – now, because I
was encouraged by mentors,
I pursued my chosen field.
Dr. Dessa Sadovnick, director,
Western-Pacific endMS RRTC
Today, the importance of gene/
environment interactions in MS
susceptibility, pathogenesis and
prognosis is a major focal point
for MS research.
As director of the Western-Pacific
endMS RRTC, I know it’s crucial
for RRTCs to educate students
about MS research as a possible
avenue. RRTCs fulfill the important
role of broadening the scope of
MS research, engaging students
and researchers in peripheral
fields that have relevance to MS
research, such as occupational
therapy, psychology and nutrition,
in addition to the many facets of MS
research itself. The overall goal of
the RRTCs is to attract and shape
well-rounded researchers who will
understand both the science of MS
and the real impact of the disease
on a person’s life.

NeTwoRk gRowTh:
Number of researchers and
trainees in the endMS Network
n Researchers
n Trainees
n Other MS-related professionals
endMS Regional Research and Training Centres
Five collaborative endMS Regional Research and Training Centres
(RRTCs) across Canada form an integrated nationwide network of
engaged trainees, clinicians and researchers. Facilitating collaboration
and encouraging the sharing of ideas, the RRTCs design and deliver
workshops, research conferences, journal clubs, inter-institution
research transfers, traineeships and mentorship programs to students
at all levels, from undergraduates to post-doctoral fellows.
RRTCs host national programs such as the endMS Summer School,
SPRINT and the endMS Conference. Their role is to provide the tools
and resources for trainees to maximize their MS research careers, or
learn more about MS research if they are considering the field.
RRTCs across the country are generously funded by:
Alberta Ministry of Enterprise and Advanced Education
Scotiabank
Fondation J. Armand Bombardier
Reimer Express Foundation
Novartis Pharmaceuticals Canada Inc.
For more information on the RRTCs, visit mssociety.ca/
RegionalCentres
500
400
300
200
100
0
e n d M S C a M p a i g n i M p a C t R e p o R t
2009 2010 2011 2012
“
I know the stress of having a
young child with MS and the
daily struggles the disease
brings to these children, who
themselves don’t understand
what’s going on with their
bodies. My son Tyrell has been
part of many studies at Sick
Kids, and we believe that a
cure will be found thanks to
researchers who are part of
the endMS Network.
”
— Stephanie, mother of
Tyrell, who was diagnosed
with MS at the age of six
e n d M S . c a 4 | 5

Train
You helped train the next generation of researchers to
discover new ways to look at MS.
endMS Summer School
Joshua Lee on the impact of the endMS Summer School
I was introduced to MS research
near the end of my bachelor’s
degree in microbiology and
immunology at the University of
British Columbia. After graduation,
I started my master’s degree
and began work in Dr. Dessa
Sadovnick’s lab, where I began
studying MS in Asian populations.
I have continued this work as a
PhD student, and I have chosen
to dedicate my career to
MS research. I want to
discover more about
the genetic and
environmental factors
in MS susceptibility
and severity, and
how those
elements
interact.
I have attended three consecutive
endMS Summer School programs.
While I have a strong foundation in
MS research, the endMS Summer
Schools exposed me to areas of
research I otherwise would not
be familiar with. The first summer
school I attended focused on the
neuropsychological effects of MS,
and it gave me ideas on how to
integrate this aspect of MS in my
own research.
The endMS Summer School
program engenders a collaborative,
collegial environment for the next
generation of MS researchers.
I enjoyed being able to connect
with other young trainees in the
same boat as me, in the spirit of
collaboration now and collaboration
in the future. I am proud to be part
of this group and hope to one day
also be proud of the role I will play
in ending MS.
Joshua Lee, MS research
trainee and three-time endMS
Summer School attendee

endMS Summer School
endMS Summer School is an annual interactive education program
that aims to enhance knowledge and skill in MS research among
students at the master, doctoral and postdoctoral/clinical fellowship
levels. It provides young MS trainees with a unique collaborative training
opportunity designed to foster their interest in MS research and support
their pursuit of knowledge in this field.
Each year, the endMS Summer School brings together students from
a variety of disciplines to learn about MS research topics. The program
features lecture-based plenary sessions and facilitated workshops that
place emphasis on creating an interdisciplinary agenda, which provides
participants a comprehensive understanding of either basic science or
clinical and population health research.
For more information on the endMS Summer School, visit
mssociety.ca/SummerSchool
e n d M S C a M p a i g n i M p a C t R e p o R t
each year, the endMS Summer School opens its doors to over 40 MS research trainees in Canada. In total,
over 150 attendee spots have been filled for the endMS Summer School since it began. over 80 per cent
of endMS Summer School attendees rated the program as “very effective” or “effective”.
The 2010 and 2011 endMS Summer Schools
were generously funded by Deloitte.
“
As a mom and the second
person in my family diagnosed
with MS, I will always wonder
if I have passed along a
genetic weakness that would
increase my daughters’
chances of having MS. I hope
that, as they collaborate and
share ideas, researchers will
solve the genetic piece of the
MS puzzle and help end MS.
— Marilyn, diagnosed in 2000
”
e n d M S . c a 6 | 7

Retain
You helped retain researchers in the field of MS.
endMS Transitional Career Development Award
Dr. Steven Kerfoot on the impact of the Garrett Herman endMS Transitional
Career Development Award (TCDA)
Before receiving the Garrett
Herman endMS Transitional Career
Development Award, I was doing
B cell immunology work in the
United States. Through previous
research collaboration, I was
encouraged to apply for the award
because my work was relevant to
the field of MS. Being selected as
the recipient of the award attracted
me to the MS research community
in Canada, where I now hold an
assistant professor position at
Western University.
My research looks at how B
cells activate T cells in chronic
autoimmune disease in the central
nervous system. I’m working to
identify subsets of B cells that
have a pathogenic role, which
could open doors to improve MS
therapies. I am also working to
obtain a clearer picture of the
immune system and how it drives
chronic inflammation in MS.
Equipment and laboratory staff are
expensive, and funding agencies
have significantly cut back on
what they’re able to fund. Without
this award, I would have been set
back months or years trying to get
funding. This award has allowed me
to invest in the research tools that
are necessary for me to carry out
my work and achieve my goals. It
has empowered me to accelerate
the pace of discovery in MS
research in Canada.
Dr. Steven Kerfoot, recipient of the
Garrett Herman endMS Transitional
Career Development Award

TCDA recipients
Garrett Herman endMS
Transitional Career
Development Award
Dr. steven Kerfoot
Western University
Research focus: Role of B cells
in multiple sclerosis
Women against Ms (WaMs)
endMS Transitional Career
Development Award
Dr. cornelia laule
University of British Columbia
Research focus: Developing
magnetic resonance (MR)
techniques to study the
pathology of MS
endMS Transitional Career Development Award
eMD serono endMS
Transitional Career
Development Award
Dr. Manu Rangachari
Brigham and Women’s Hospital
at Harvard Medical School
Research focus: Pathogenic
role of T cells in a mouse
model of MS
The endMS Transitional Career Development Award program supports
outstanding postdoctoral and clinical fellows who are currently
conducting research in an area related to MS.
The award provides Canadian researchers with the means to establish
a strong foundation for their MS-focused independent research career.
This $500,000 award funds the last two years of the award recipient’s
postdoctoral study and the first three years of their independent MSrelated
faculty position in a Canadian institution. This award would not be
possible without the generous support of those donors who funded the
award in its entirety each year.
For more information on the TCDA, visit mssociety.ca/TCDA
e n d M S C a M p a i g n i M p a C t R e p o R t
David l. torrey endMS
Transitional Career
Development Award
Dr. Jorge alvarez
University of Montréal Hospital
Research Centre
Research focus: Central
nervous system barriers and
how they may be involved in
MS-related inflammation
“
Decker family endMS
Transitional Career
Development Award
Dr. Jiwon oh
Johns Hopkins University
Research focus: Using
advanced MRI techniques to
determine how spinal cord
lesions cause sensorimotor
deficits
Researchers like Dr. Kerfoot
are working hard to answer
questions about a disease
that affects me every day.
The TCDA decreases some
of the funding challenges
he faces as a researcher
and ensures his commitment
to MS research to develop
treatments that help
”
me manage my disease.
— Marie, diagnosed in 1996
e n d M S . c a 8 | 9

Collaborate
You helped increase opportunities for collaborative MS research.
endMS Scholar Program for Researchers in
Training (SPRINT)
Dr. C.J. MacMillan on the impact of the endMS SPRINT program
Growing up in Atlantic Canada,
multiple sclerosis was part of my
life and those of my family and
friends. I began studying MS as a
PhD candidate in neuropathology
because of the high prevalence of
the disease in my region. During
discussions with family and friends,
it was clear to me that more
research is desperately needed.
In 2009, I was encouraged to
enrol in the SPRINT program
through my local endMS
Regional Research and Training
Centre. SPRINT’s focus on the
importance of interdisciplinary
and collaborative research
piqued my interest. Like
me, several of the program
participants focus their research
on neuropathology, while others
Dr. C.J. MacMillan,
SPRINT participant
focus on immunology and other
fields related to MS. My research
looks at angiogenesis – the
formation of new capillary
blood vessels in the body – and
the role it plays in MS.
SPRINT provided me with the
opportunity to make valuable
connections in the field of MS
research. During the endMS
Summer School, I was able to
collaborate with two trainees and
a mentor on a project. I now have
the skills necessary to effectively
participate in collaborative
research and translate my basic
science research findings into
everyday practice. SPRINT has
been critical in my development
as a trainee and inspired me to
continue my pursuit for answers.

endMS SPRINT program
SPRINT supports graduate students and postdoctoral and clinical fellows
who are interested in conducting MS research. The program aims to enhance
trainees’ knowledge and skill in MS research by increasing opportunities
for collaborative MS research and creating a peer network. Trainees
participate in two consecutive endMS Summer School sessions and a career
development session before they are paired with a mentor.
For more information on SPRINT, visit mssociety.ca/SPRINT
endMS Conference
The endMS Conference is a national research conference aimed at fostering
knowledge exchange on MS-related research, networking opportunities
and collaboration amongst researchers and trainees. The three-day event
features lectures, workshops, poster sessions and networking opportunities.
It enables participants to learn about other research taking place in Canada
and to present and receive feedback on their work.
endMS Conference attendance
2013: Forthcoming in Saint-
Sauveur, QC
2010: 207 attendees, Whistler, BC
2007: 225 attendees, Banff, AB
For more information on the
endMS Conference, visit
mssociety.ca/conference
e n d M S C a M p a i g n i M p a C t R e p o R t
“
As I manage my multiple
sclerosis, I look to research
for possible answers about my
future health. The SPRINT
program gives me hope, as it
lets me know the best and
brightest minds are learning
and collaborating with each
other to find those answers.
— Carol, diagnosed in 2003
”
e n d M S . c a 10 | 11

Research
You helped fund invaluable MS research in Canada. Thank you.
MS Society research program
The endMS campaign contributed $60 million to the MS Society research
program, which funds work in several research areas across the country in addition
to the campaign’s flagship investment of the endMS Research and Training
Network, designed to boost the research program. Because of you, the MS Society
and the Multiple Sclerosis Scientific Research Foundation are able to annually
spend $8 to $10 million on research to find the cause of MS, treat symptoms and
improve quality of life, and ultimately discover a cure for the disease.
The MS Society funds as many promising avenues of research as possible, such
as remyelination, cell signalling, CCSVI and stem cell research, so that researchers
may answer the many questions that remain about MS. The following chart
illustrates the many areas of research we fund so that people living with MS may
have the answers they seek.
MS Society research program: What we fund
n Neuroimmunology: 23%
n MRI studies: 12%
n Remyelination: 12%
n Cell signalling: 12%
n Preclinical models: 10%
n Therapeutics: 7%
n Quality of life: 6%
n Population health: 5%
n Neuropathology: 4%
n Cognitive impairment: 3%
n Genetics: 3%
n Etiology: 2%
n Stem cells: 1%

Research we fund: Looking for answers
eTIology: What causes multiple sclerosis?
Finding answers: Dr. Christina Wolfson, McGill University
A population study of risk factors for multiple
sclerosis: The Canadian contribution to an
international study
The cause of MS remains unknown despite more than 100
years of research. Researchers have, however, determined
a few possible individual risk factors, including infectious
agents, smoking and vitamin D deficiency. A team of MS
researchers from Europe and Canada are conducting
a study including participants from five countries with
differing MS risk that is large enough to examine how the
factors work together. Once completed, this case control
will be the largest MS risk factor study ever conducted.
QuAlITy oF lIFe AND CogNITIve IMPAIRMeNT:
How do I cope with the invisible cognitive
symptoms of MS?
Finding answers: Dr. Neil Rector, Sunnybrook Research
Institute
A randomized controlled trial testing the additive
benefits of CBT and exercise for depression and
cognitive dysfunction in MS
Multiple sclerosis is a disease that can cause depression
and cognitive deficits, which affect at least half of people
living with MS. Dr. Rector investigates the effects of
cognitive behavioural therapy, exercise and a combination
of both on depression and neuropsychological functioning
in MS to enable people living with MS to improve their
quality of life.
e n d M S C a M p a i g n i M p a C t R e p o R t
ReMyelINATIoN: Can the myelin damage caused by
MS be reversed?
Finding answers: Dr. Jack Antel, McGill University
Cellular immune injury of human oligodendrocytes
The neurologic deficits in MS are a consequence of
injury and loss of myelin and the oligodendrocyte (OL) in
the central nervous system. Dr. Antel’s work examines
MS lesions to study how OLs may be injured by several
mechanisms, and why they are unable to trigger
remyelination after damage done due to MS. The results
from this study may lead to remyelination treatments that
would repair the central nervous system.
NeuRoIMMuNology: Why does the immune system
malfunction in MS to attack the central nervous system?
Finding answers: Dr. Robin Yates, University of Calgary
Exploring the mechanisms of myelin antigen
processing within the endosomal systems of
macrophages and dendritic cells
MS is a disease wherein immune cells (T-cells) mistakenly
react to their own proteins in myelin, resulting in
neurologic impairment. While autoimmune T-cells trigger
the inflammation seen in the disease, it is the antigen
presenting cells (APCs) that engulf myelin debris that are
responsible for activating the T-cells in the first place. Dr.
Yates investigates how modifying the way APCs digest
protein may eventually render it possible to control MS
while maintaining beneficial immune responses.
e n d M S . c a 12 | 13

Research
Multiple Sclerosis Scientific Research Foundation
The MS Society also funds the Multiple Sclerosis Scientific Research Foundation to
stimulate innovative and collaborative research that will lead to major advances in MS.
These funds support large, multi-centre, collaborative studies that are beyond the
scope of the regular research program.
Prospective study of the clinical
epidemiology, pathobiology and
neuroimaging features of Canadian
children with acquired demyelinating
syndromes
$4,300,000
This study is designed to better
understand the symptoms of
demyelination in children. By comparing
the features of children diagnosed
with MS to the features of children
who experience a full recovery from
an isolated attack of demyelination,
researchers hope to learn important
information about the causes of MS.
Dr. Brenda Banwell, Children’s
Hospital of Philadelphia (study taking
place at Hospital for Sick Children,
Toronto)
Pathobiology of MS:
Complex interplay between
degeneration and inflammation
$3,800,000
While the cause of brain inflammation
and degeneration in MS is unknown,
it is apparent that this vicious cycle
drives tissue damage and patient
disability. This team project will study
the molecular mechanisms of how nerve
fibres are permanently injured in the
brain and spinal cord of MS patients to
better understand what happens in the
earliest phases of this disease, which
may have significance for people living
with progressive forms of MS.
Dr. Peter Stys, University of Calgary
For complete information on
MS Society funded research, visit
mssociety.ca/researchsummaries

endMS campaign: Our valued donors
endMS Circle ($1,000,000+)
Alberta Ministry of Enterprise &
Advanced Education
Astral Media
Canwest Global
The Waugh Family Foundation
Breakthrough Circle
($500,000-$999,999)
BMO Financial Group
CIBC
Bob & Pat Decker
EMD Serono
Garrett Herman
Louis J. Maroun
Scotiabank
David L. Torrey
Women Against MS (WAMS)
Anonymous
Discovery Circle
($250,000-$499,999)
Don Barkwell
The Rudolph P. Bratty Family
Foundation
The Goodman Family and the
Dundee Group of Companies
Manulife Financial
Polygon Homes Limited
Power Corporation of Canada
Rogers Communications
Shaw Communications Inc.
Anonymous
knowledge Circle
($100,000-$249,999)
Sandy & Margot Aird
Biogen Idec Canada Inc.
Fondation J. Armand Bombardier
The John & Judy Bragg Family
Foundation
La Capsule sportive, MSA financial
and Houston Golf Tournament
Albert Diamond Cohen
Purdy & Bea Crawford
Ian & Kiki Delaney
Deloitte & Touche Foundation
Canada
Ernst & Young LLP
FRQS (Fonds de recherche du
Québec - Santé)
Jayman MasterBUILT
KPMG Foundation
Jon & Nancy Love
Debbie & Fred Moore
Susan A. Murray
National Bank Financial Group
Robert H. Pitfield
Larry Plotnick, with family & friends
PricewaterhouseCoopers LLP
Reimer Express Foundation
Research In Motion Limited
Bruce & Sylvia Richmond
Sherritt International Corporation
Joanne Stansfield & Bill Gallacher
Kevin & Sandra Sullivan
Larry & Judy Tanenbaum
TELUS
Richard & Heather Thomson
Anonymous
Patron
($50,000-$99,999)
Altus Energy Services Partnership
Bob & Joy Antenbring
Gayelene Bonenfant
Brandt Group of Companies
Dr. F.J. Brooks-Hill
Richard Charlton
Co-operators
Costco Wholesale Canada Ltd.
John Feld & Phyllis Yaffe
Alistair M. Fraser
GMP Securities
IBM Canada
Milan & Maureen Ilich Foundation
Industrielle Alliance
Jazz Air LP
Peter & Allison Jelley
Daniel Larouche
Kenneth Macgowan
e n d M S C a M p a i g n i M p a C t R e p o R t
We are grateful to the following donors who have contributed to the endMS campaign.
Novartis Pharmaceuticals Canada
Inc.
Onex Corporation
Riddell Family Charitable Foundation
SNC-Lavalin
Teva Canada Innovation
Mark & Sarah Wellings
Herbert Wyman
Anonymous (3)
Benefactor
($25,000-$49,999)
Ainsworth Charitable Trust
Avtar Bains & Monika Deol
Bay Tank & Vessel Ltd.
Stewart Busbridge
The Charlton Group
CN
John F. Clifford
Donald & Valerie Copeland
Cuddy Farms Corporation,
in memory of A.M. Cuddy
The Cullen Family
Rueben & Rhonda Devlin
George Fine
David & Beverly Garton
Gibson Energy
Goodman Investment Counsel
Barry Gordon Family
Haywood Securities Inc.
Highland Farms Inc.
Helen Kearns
David L. Knight
Laval Chapter, MS Society of Canada
Harold & Yvonne Lenfesty
John & Gail MacNaughton
Terry McGibbon
David McGraw
McMillan LLP
Kathleen Murphy & Harry Joosten
J.E. Panneton Family Foundation
Paradigm Capital
Peak Energy Services Trust
Honourable Madam Justice Sarah
Pepall
Phillips, Hager & North Investment
Management Ltd.
Pollard Family Foundation
Marjorie Anne Sauder
Yves Savoie
Sun Life Financial
William D. Swisher
Trudell Medical International, in
memory of A.M. Cuddy
Gabriel Tsampalieros
Anonymous
leader
($10,000-$24,999)
Paul Atkinson
Rob Barbara
The Bellini Foundation
Michael Bernstein & Nandini
DasGupta
Gil Blutrich
Bosa Properties Foundation
Canadian Western Bank
Frances Carmichael & Jack Cashman
Barry & Laurie Cavanaugh
Neil & Andrea Chrystal
Norm Cressey
Rossano DeCottis
Dinner and Jazz for MS
Elan Pharmaceuticals
Emerson Real Estate Group
Lindsay & Elizabeth Gordon
Glen Gowland
Sam & Sally Grippo
Stanley H. Hartt
In honour of Susan Huycke & Sylvia
Bosworth
The Dick & Lois Haskayne Fund at
The Calgary Foundation
Chris Haslam
Ramsay Holmes
HUB International
I.M.P. Group International Inc.
ING Direct
Richard Ilich & Lauren Melville
e n d M S . c a 14 | 15

Our valued donors (continued)
leader
($10,000-$24,999)
(continued)
Ralph Jordan
Andy Kent
The Henry White Kinnear Foundation
Jack Kowarsky & Maya Coco
Peter & Kay Legge
Brian D. Lerner
Loewen Ondaatje McCutcheon Ltd.
Lohn Foundation
Samuel & Vivien Ludwin
William S. & Jana Maclagan
Macquarie Group Foundation
Hugh & Sherri Magee
George Marlatte
Andrew Mahon Foundation
Ken & Suzanne Mayhew
Nixon Charitable Foundation
Leslie Noble
Daniel Nowlan
Onni Group
Herb & Aster Osen
Maria Pinelli & Paul Fletcher
David & Mary Beth Poole
Jack & Darlene Poole
Procura Real Estate Services Limited
Joe Randell
Larry & Grethe Rank
Jim & Marcia Ratsoy
RBC Capital Markets
Jeffrey C. Rice
The Rix Family Foundation
Rollagain Holdings
Sassafraz
William L. Sauder
Scotia Capital
The Joseph Segal Family Foundation
Michael Shuh & Michelle Fiebig
Sidoo Family Foundation
South Edmonton Lions Club
Thane & Darci Stenner
Torys LLP
Variety - The Children’s Charity of
British Columbia
Warrior Resources Corporation
Wesik Construction Limited
The James & Kathleen Winton
Foundation
Anonymous (5)
Investor
($5,000-$9,999)
AllianceBernstein Canada, Inc.
Aurion Capital
David Bardal
Bell Aliant
Bio-Extraction Inc.
BioMS Medical Corp.
Bonavista Energy Corporation
Yolanda Bronstein
Sushil & Diana Chari
Mr. Peter Cashin of Quest Rare
Minerals
CI Investments Inc.
Colliers International
Mike den Haan & Family
David Doritty
Charles J. Ford
Richard Grafton
Halifax International Airport Authority
Dominique Hansen
Kelly Heed
Sibylla Hesse Foundation
Sean Hodgins
The Hon. Henry N.R. Jackman
Jolera
Brian Jones
Greg & Lisa Kerfoot
Morley & Myrna Koffman
Douglas C. & Ann Mackay
Joan MacKinnon
Robert & Debra MacLeod
Keith MacPhail
Martinrea International Inc.
Senator Paul J. Massicotte & Sylvie
Dragon
Medcan Clinic
Mike McClintock
Seth & Theresa Mersky
Oberon Capital
Lisa & Roger Park
Gestion Picory Inc.
Raymond James
The Larry & Cookie Rossy Family
Foundation
Rohit Sehgal
The Shaw Group
Shelter Canadian Properties Inc.
Dena Simon
Peter Smiechowski
Sterling Senior Living
Stoneham Drilling Inc.
TNG Corporation
Waterbury Newton
Jack Way
Brendan Wood International
Woods LLP
Anonymous
Supporter
($1,000-$4,999)
Michelle Amerie & Raymond Cohen
Apex Distribution Inc.
Joshua Arbuckle
Larry Arsenault
The Azrieli Foundation
Brent S. Belzberg
Herbert Black
Chris Breen
Elizabeth Breen
Department of Microbiology &
Immunology, University of British
Columbia
Dennis and Darla Brown
Burgundy Asset Management Ltd.
Dr. Greg A. Burk
CAE Inc.
Fiona A. Campbell
Jennifer Carter
David Christie
Jacqui Cohen/Army & Navy Stores
Concord Pacific Group Inc.
Patricia Davidson
Douglas Deruchie
Discovery Solutions International Inc.
Leslie & Irene Dube
Rick Durst
Geoffrey J. Dyer
Jonathan Ehrlich
Brad Forden & Carole Fujimoto
Ian Fraser
GARAGA Inc.
Natasha Hughes Germain
Judy Goldring
Jeff & Sandra Goldstein
Bill Gray
Greater Toronto Airport Authority
Rohit & Aimee Gupta
Richard Hodgson
Valerie Hussey Family Fund via Tides
Canada Foundation
Greg Kalil
Dr. Stephen Kerfoot
Sass & Sharmeen Khazzam
Gene & Cathy Kosmyna
Kevin Li & Lori Sugarman
Larry R. Lunn
Craig Macadam
Larry Maloney
Tammy Masoumi
The Jeffrey & Marilyn McCaig Family
Foundation
James C. McKnight
Mitchell McConnell Insurance Ltd.
Dr. Jock & Janet Murray
Norton Rose
Fred & Gail Pamenter
Paul Pathak
David G. Patterson
Piston Ring Service
Alexandre Prat
Quebecor World Inc.
Jeremy Rakusin
Jonathan Robbins
Mahon Rowland Foundation
Irene Russell
Dr. Dessa Sadovnick
David Sapunjis – Sapunjis Family
Trust
Alan M. Schwartz
Selective Asset Management Inc.
Robert Sellars
Shaw Pipe Limited
La maison Simons
Allen Stern
Stock Network Media
Lyane Van Schank-Munk
Victoria Foundation
C.J. Viner Family Foundation
John Webb
Waterloo Chapter, MS Society of
Canada -- Fall Fashion Fantasy Show
Stephen Waugh
Mark Whitmore
Anonymous (5)
We apologize for any errors or omissions.

e n d M S n a t i o n a l C a M p a i g n C a b i n e t *
Honorary national
campaign chair
Mr. Richard E. Waugh
National campaign chair
Mr. Alexander R. Aird
National campaign
vice-chairs
Mr. Purdy Crawford
Ms. Helen M. Kearns
Quebec campaign chair
Mr. Claude Gagnon
Ontario campaign chair
Mr. David A. Garton
BC-Yukon
campaign chair
Mr. David M. Poole
Atlantic campaign chair
Mr. Joseph D. Randell
Cabinet members
Mr. Alistair M. Fraser
Mr. Stanley H. Hartt
Mr. Garrett Herman
Mr. Daniel Larouche
Mr. Louis J. Maroun
Mr. Fred Moore
Mr. Bryan Rakusin
Mr. Bruce R. Richmond
Mr. Yves Savoie
Mr. Richard M. Thomson
Mr. David L. Torrey
*List from December 2012

1-800-268-7582 info@mssociety.ca mssociety.ca
FSC logo